nodes	percent_of_prediction	percent_of_DWPC	metapath
Sufentanil—CYP3A4—Bexarotene—hematologic cancer	0.0482	0.0829	CbGbCtD
Sufentanil—CYP3A4—Lomustine—hematologic cancer	0.0448	0.0771	CbGbCtD
Sufentanil—CYP3A4—Busulfan—hematologic cancer	0.0448	0.0771	CbGbCtD
Sufentanil—CYP3A4—Thiotepa—hematologic cancer	0.0399	0.0687	CbGbCtD
Sufentanil—CYP3A4—Methoxsalen—hematologic cancer	0.031	0.0534	CbGbCtD
Sufentanil—CYP3A4—Bortezomib—hematologic cancer	0.0295	0.0508	CbGbCtD
Sufentanil—CYP3A4—Daunorubicin—hematologic cancer	0.0282	0.0486	CbGbCtD
Sufentanil—CYP3A4—Cytarabine—hematologic cancer	0.0249	0.0429	CbGbCtD
Sufentanil—CYP3A4—Teniposide—hematologic cancer	0.0245	0.0422	CbGbCtD
Sufentanil—CYP3A4—Ifosfamide—hematologic cancer	0.0226	0.039	CbGbCtD
Sufentanil—CYP3A4—Imatinib—hematologic cancer	0.0216	0.0372	CbGbCtD
Sufentanil—CYP3A4—Ruxolitinib—hematologic cancer	0.0204	0.0351	CbGbCtD
Sufentanil—CYP3A4—Nilotinib—hematologic cancer	0.0197	0.0338	CbGbCtD
Sufentanil—CYP3A4—Vinorelbine—hematologic cancer	0.0195	0.0335	CbGbCtD
Sufentanil—CYP3A4—Triamcinolone—hematologic cancer	0.0178	0.0307	CbGbCtD
Sufentanil—CYP3A4—Dasatinib—hematologic cancer	0.0174	0.0299	CbGbCtD
Sufentanil—CYP3A4—Mitoxantrone—hematologic cancer	0.0172	0.0295	CbGbCtD
Sufentanil—CYP3A4—Betamethasone—hematologic cancer	0.0153	0.0263	CbGbCtD
Sufentanil—CYP3A4—Prednisolone—hematologic cancer	0.0151	0.026	CbGbCtD
Sufentanil—CYP3A4—Prednisone—hematologic cancer	0.0143	0.0245	CbGbCtD
Sufentanil—CYP3A4—Irinotecan—hematologic cancer	0.0135	0.0233	CbGbCtD
Sufentanil—CYP3A4—Vinblastine—hematologic cancer	0.012	0.0207	CbGbCtD
Sufentanil—CYP3A4—Vincristine—hematologic cancer	0.0118	0.0203	CbGbCtD
Sufentanil—CYP3A4—Etoposide—hematologic cancer	0.0108	0.0186	CbGbCtD
Sufentanil—CYP3A4—Dexamethasone—hematologic cancer	0.0089	0.0153	CbGbCtD
Sufentanil—CYP3A4—Doxorubicin—hematologic cancer	0.00738	0.0127	CbGbCtD
Sufentanil—Alfentanil—ALB—hematologic cancer	0.000278	0.434	CrCbGaD
Sufentanil—Alfentanil—ABCB1—hematologic cancer	0.000265	0.414	CrCbGaD
Sufentanil—Rash—Lenalidomide—hematologic cancer	0.000254	0.000794	CcSEcCtD
Sufentanil—Body temperature increased—Carmustine—hematologic cancer	0.000253	0.000793	CcSEcCtD
Sufentanil—Dermatitis—Lenalidomide—hematologic cancer	0.000253	0.000793	CcSEcCtD
Sufentanil—Hypotension—Cisplatin—hematologic cancer	0.000253	0.000792	CcSEcCtD
Sufentanil—Vomiting—Hydroxyurea—hematologic cancer	0.000252	0.000789	CcSEcCtD
Sufentanil—Headache—Lenalidomide—hematologic cancer	0.000252	0.000789	CcSEcCtD
Sufentanil—Body temperature increased—Alitretinoin—hematologic cancer	0.000251	0.000786	CcSEcCtD
Sufentanil—Rash—Hydroxyurea—hematologic cancer	0.00025	0.000783	CcSEcCtD
Sufentanil—Erythema—Dexamethasone—hematologic cancer	0.00025	0.000783	CcSEcCtD
Sufentanil—Erythema—Betamethasone—hematologic cancer	0.00025	0.000783	CcSEcCtD
Sufentanil—Confusional state—Etoposide—hematologic cancer	0.00025	0.000783	CcSEcCtD
Sufentanil—Dermatitis—Hydroxyurea—hematologic cancer	0.00025	0.000782	CcSEcCtD
Sufentanil—Cardiac arrest—Doxorubicin—hematologic cancer	0.000249	0.000779	CcSEcCtD
Sufentanil—Headache—Hydroxyurea—hematologic cancer	0.000248	0.000778	CcSEcCtD
Sufentanil—Body temperature increased—Ifosfamide—hematologic cancer	0.000248	0.000777	CcSEcCtD
Sufentanil—Anaphylactic shock—Etoposide—hematologic cancer	0.000248	0.000776	CcSEcCtD
Sufentanil—Hypersensitivity—Thalidomide—hematologic cancer	0.000246	0.00077	CcSEcCtD
Sufentanil—Nausea—Melphalan—hematologic cancer	0.000246	0.000769	CcSEcCtD
Sufentanil—Feeling abnormal—Mitoxantrone—hematologic cancer	0.000246	0.000769	CcSEcCtD
Sufentanil—Feeling abnormal—Irinotecan—hematologic cancer	0.000246	0.000769	CcSEcCtD
Sufentanil—Dizziness—Bortezomib—hematologic cancer	0.000245	0.000766	CcSEcCtD
Sufentanil—Anaphylactic shock—Prednisolone—hematologic cancer	0.000245	0.000766	CcSEcCtD
Sufentanil—Pruritus—Thiotepa—hematologic cancer	0.000244	0.000764	CcSEcCtD
Sufentanil—Tachycardia—Etoposide—hematologic cancer	0.000242	0.000758	CcSEcCtD
Sufentanil—Body temperature increased—Vincristine—hematologic cancer	0.000242	0.000757	CcSEcCtD
Sufentanil—Feeling abnormal—Gemcitabine—hematologic cancer	0.000239	0.000749	CcSEcCtD
Sufentanil—Dizziness—Vinorelbine—hematologic cancer	0.000239	0.000748	CcSEcCtD
Sufentanil—Nausea—Lenalidomide—hematologic cancer	0.000239	0.000748	CcSEcCtD
Sufentanil—Tachycardia—Prednisolone—hematologic cancer	0.000239	0.000747	CcSEcCtD
Sufentanil—Hypertension—Triamcinolone—hematologic cancer	0.000238	0.000745	CcSEcCtD
Sufentanil—Hypersensitivity—Carmustine—hematologic cancer	0.000236	0.00074	CcSEcCtD
Sufentanil—Pruritus—Thalidomide—hematologic cancer	0.000236	0.000739	CcSEcCtD
Sufentanil—Body temperature increased—Mitoxantrone—hematologic cancer	0.000236	0.000738	CcSEcCtD
Sufentanil—Body temperature increased—Irinotecan—hematologic cancer	0.000236	0.000738	CcSEcCtD
Sufentanil—Nausea—Hydroxyurea—hematologic cancer	0.000236	0.000738	CcSEcCtD
Sufentanil—Vomiting—Bortezomib—hematologic cancer	0.000235	0.000737	CcSEcCtD
Sufentanil—Hypersensitivity—Alitretinoin—hematologic cancer	0.000234	0.000733	CcSEcCtD
Sufentanil—Vomiting—Bleomycin—hematologic cancer	0.000234	0.000731	CcSEcCtD
Sufentanil—Rash—Bortezomib—hematologic cancer	0.000233	0.000731	CcSEcCtD
Sufentanil—Dermatitis—Bortezomib—hematologic cancer	0.000233	0.00073	CcSEcCtD
Sufentanil—Headache—Bortezomib—hematologic cancer	0.000232	0.000726	CcSEcCtD
Sufentanil—Hypotension—Etoposide—hematologic cancer	0.000232	0.000725	CcSEcCtD
Sufentanil—Rash—Bleomycin—hematologic cancer	0.000232	0.000725	CcSEcCtD
Sufentanil—Dermatitis—Bleomycin—hematologic cancer	0.000231	0.000724	CcSEcCtD
Sufentanil—Hypersensitivity—Ifosfamide—hematologic cancer	0.000231	0.000724	CcSEcCtD
Sufentanil—Vomiting—Vinorelbine—hematologic cancer	0.00023	0.000719	CcSEcCtD
Sufentanil—Body temperature increased—Gemcitabine—hematologic cancer	0.00023	0.000719	CcSEcCtD
Sufentanil—Dizziness—Thiotepa—hematologic cancer	0.000228	0.000715	CcSEcCtD
Sufentanil—Rash—Vinorelbine—hematologic cancer	0.000228	0.000713	CcSEcCtD
Sufentanil—Dermatitis—Vinorelbine—hematologic cancer	0.000228	0.000713	CcSEcCtD
Sufentanil—Headache—Vinorelbine—hematologic cancer	0.000226	0.000709	CcSEcCtD
Sufentanil—Hypersensitivity—Vincristine—hematologic cancer	0.000225	0.000706	CcSEcCtD
Sufentanil—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000225	0.000704	CcSEcCtD
Sufentanil—Pruritus—Alitretinoin—hematologic cancer	0.000225	0.000704	CcSEcCtD
Sufentanil—Arrhythmia—Prednisone—hematologic cancer	0.000223	0.0007	CcSEcCtD
Sufentanil—Feeling abnormal—Cisplatin—hematologic cancer	0.000223	0.000698	CcSEcCtD
Sufentanil—Pruritus—Ifosfamide—hematologic cancer	0.000222	0.000695	CcSEcCtD
Sufentanil—Dizziness—Thalidomide—hematologic cancer	0.000221	0.000691	CcSEcCtD
Sufentanil—Somnolence—Etoposide—hematologic cancer	0.00022	0.00069	CcSEcCtD
Sufentanil—Nausea—Bortezomib—hematologic cancer	0.00022	0.000688	CcSEcCtD
Sufentanil—Hypersensitivity—Irinotecan—hematologic cancer	0.00022	0.000688	CcSEcCtD
Sufentanil—Hypersensitivity—Mitoxantrone—hematologic cancer	0.00022	0.000688	CcSEcCtD
Sufentanil—Tachycardia—Triamcinolone—hematologic cancer	0.000219	0.000687	CcSEcCtD
Sufentanil—Vomiting—Thiotepa—hematologic cancer	0.000219	0.000687	CcSEcCtD
Sufentanil—Nausea—Bleomycin—hematologic cancer	0.000218	0.000683	CcSEcCtD
Sufentanil—Erythema—Prednisone—hematologic cancer	0.000218	0.000682	CcSEcCtD
Sufentanil—Rash—Thiotepa—hematologic cancer	0.000218	0.000681	CcSEcCtD
Sufentanil—Dermatitis—Thiotepa—hematologic cancer	0.000217	0.000681	CcSEcCtD
Sufentanil—Headache—Thiotepa—hematologic cancer	0.000216	0.000677	CcSEcCtD
Sufentanil—Hypertension—Betamethasone—hematologic cancer	0.000216	0.000676	CcSEcCtD
Sufentanil—Hypertension—Dexamethasone—hematologic cancer	0.000216	0.000676	CcSEcCtD
Sufentanil—Nausea—Vinorelbine—hematologic cancer	0.000215	0.000672	CcSEcCtD
Sufentanil—Body temperature increased—Cisplatin—hematologic cancer	0.000214	0.00067	CcSEcCtD
Sufentanil—Vomiting—Thalidomide—hematologic cancer	0.000212	0.000665	CcSEcCtD
Sufentanil—Dizziness—Carmustine—hematologic cancer	0.000212	0.000664	CcSEcCtD
Sufentanil—Rash—Thalidomide—hematologic cancer	0.00021	0.000659	CcSEcCtD
Sufentanil—Dermatitis—Thalidomide—hematologic cancer	0.00021	0.000658	CcSEcCtD
Sufentanil—Dizziness—Alitretinoin—hematologic cancer	0.00021	0.000658	CcSEcCtD
Sufentanil—Headache—Thalidomide—hematologic cancer	0.000209	0.000655	CcSEcCtD
Sufentanil—Dizziness—Ifosfamide—hematologic cancer	0.000208	0.00065	CcSEcCtD
Sufentanil—Urinary tract disorder—Methotrexate—hematologic cancer	0.000206	0.000646	CcSEcCtD
Sufentanil—Pruritus—Gemcitabine—hematologic cancer	0.000205	0.000643	CcSEcCtD
Sufentanil—Nausea—Thiotepa—hematologic cancer	0.000205	0.000642	CcSEcCtD
Sufentanil—Urethral disorder—Methotrexate—hematologic cancer	0.000205	0.000641	CcSEcCtD
Sufentanil—Feeling abnormal—Etoposide—hematologic cancer	0.000204	0.00064	CcSEcCtD
Sufentanil—Anaphylactic shock—Betamethasone—hematologic cancer	0.000204	0.000639	CcSEcCtD
Sufentanil—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000204	0.000639	CcSEcCtD
Sufentanil—Vomiting—Carmustine—hematologic cancer	0.000204	0.000638	CcSEcCtD
Sufentanil—Dizziness—Vincristine—hematologic cancer	0.000202	0.000634	CcSEcCtD
Sufentanil—Rash—Carmustine—hematologic cancer	0.000202	0.000633	CcSEcCtD
Sufentanil—Dermatitis—Carmustine—hematologic cancer	0.000202	0.000632	CcSEcCtD
Sufentanil—Vomiting—Alitretinoin—hematologic cancer	0.000202	0.000632	CcSEcCtD
Sufentanil—Feeling abnormal—Prednisolone—hematologic cancer	0.000202	0.000631	CcSEcCtD
Sufentanil—Headache—Carmustine—hematologic cancer	0.000201	0.000629	CcSEcCtD
Sufentanil—Rash—Alitretinoin—hematologic cancer	0.0002	0.000627	CcSEcCtD
Sufentanil—Dermatitis—Alitretinoin—hematologic cancer	0.0002	0.000626	CcSEcCtD
Sufentanil—Vomiting—Ifosfamide—hematologic cancer	0.0002	0.000625	CcSEcCtD
Sufentanil—Hypersensitivity—Cisplatin—hematologic cancer	0.000199	0.000624	CcSEcCtD
Sufentanil—Tachycardia—Betamethasone—hematologic cancer	0.000199	0.000623	CcSEcCtD
Sufentanil—Tachycardia—Dexamethasone—hematologic cancer	0.000199	0.000623	CcSEcCtD
Sufentanil—Bradycardia—Epirubicin—hematologic cancer	0.000199	0.000623	CcSEcCtD
Sufentanil—Headache—Alitretinoin—hematologic cancer	0.000199	0.000623	CcSEcCtD
Sufentanil—Nausea—Thalidomide—hematologic cancer	0.000198	0.000621	CcSEcCtD
Sufentanil—Rash—Ifosfamide—hematologic cancer	0.000198	0.00062	CcSEcCtD
Sufentanil—Dermatitis—Ifosfamide—hematologic cancer	0.000198	0.000619	CcSEcCtD
Sufentanil—Dizziness—Irinotecan—hematologic cancer	0.000197	0.000617	CcSEcCtD
Sufentanil—Body temperature increased—Etoposide—hematologic cancer	0.000196	0.000614	CcSEcCtD
Sufentanil—Vomiting—Vincristine—hematologic cancer	0.000195	0.000609	CcSEcCtD
Sufentanil—Urinary tract disorder—Epirubicin—hematologic cancer	0.000193	0.000605	CcSEcCtD
Sufentanil—Rash—Vincristine—hematologic cancer	0.000193	0.000604	CcSEcCtD
Sufentanil—Dermatitis—Vincristine—hematologic cancer	0.000193	0.000604	CcSEcCtD
Sufentanil—Urethral disorder—Epirubicin—hematologic cancer	0.000192	0.0006	CcSEcCtD
Sufentanil—Headache—Vincristine—hematologic cancer	0.000192	0.0006	CcSEcCtD
Sufentanil—Hypotension—Dexamethasone—hematologic cancer	0.000191	0.000597	CcSEcCtD
Sufentanil—Hypotension—Betamethasone—hematologic cancer	0.000191	0.000597	CcSEcCtD
Sufentanil—Nausea—Carmustine—hematologic cancer	0.00019	0.000596	CcSEcCtD
Sufentanil—Vomiting—Mitoxantrone—hematologic cancer	0.00019	0.000593	CcSEcCtD
Sufentanil—Vomiting—Irinotecan—hematologic cancer	0.00019	0.000593	CcSEcCtD
Sufentanil—Nausea—Alitretinoin—hematologic cancer	0.000189	0.000591	CcSEcCtD
Sufentanil—Hypertension—Prednisone—hematologic cancer	0.000188	0.000589	CcSEcCtD
Sufentanil—Rash—Irinotecan—hematologic cancer	0.000188	0.000588	CcSEcCtD
Sufentanil—Rash—Mitoxantrone—hematologic cancer	0.000188	0.000588	CcSEcCtD
Sufentanil—Dermatitis—Mitoxantrone—hematologic cancer	0.000188	0.000588	CcSEcCtD
Sufentanil—Dermatitis—Irinotecan—hematologic cancer	0.000188	0.000588	CcSEcCtD
Sufentanil—Chills—Methotrexate—hematologic cancer	0.000188	0.000587	CcSEcCtD
Sufentanil—Headache—Irinotecan—hematologic cancer	0.000187	0.000585	CcSEcCtD
Sufentanil—Headache—Mitoxantrone—hematologic cancer	0.000187	0.000585	CcSEcCtD
Sufentanil—Nausea—Ifosfamide—hematologic cancer	0.000186	0.000584	CcSEcCtD
Sufentanil—Feeling abnormal—Triamcinolone—hematologic cancer	0.000185	0.00058	CcSEcCtD
Sufentanil—Vomiting—Gemcitabine—hematologic cancer	0.000185	0.000578	CcSEcCtD
Sufentanil—Bradycardia—Doxorubicin—hematologic cancer	0.000184	0.000577	CcSEcCtD
Sufentanil—Rash—Gemcitabine—hematologic cancer	0.000183	0.000573	CcSEcCtD
Sufentanil—Dermatitis—Gemcitabine—hematologic cancer	0.000183	0.000573	CcSEcCtD
Sufentanil—Hypersensitivity—Etoposide—hematologic cancer	0.000183	0.000572	CcSEcCtD
Sufentanil—Erythema—Methotrexate—hematologic cancer	0.000182	0.00057	CcSEcCtD
Sufentanil—Headache—Gemcitabine—hematologic cancer	0.000182	0.000569	CcSEcCtD
Sufentanil—Nausea—Vincristine—hematologic cancer	0.000182	0.000569	CcSEcCtD
Sufentanil—Hypersensitivity—Prednisolone—hematologic cancer	0.00018	0.000564	CcSEcCtD
Sufentanil—Urinary tract disorder—Doxorubicin—hematologic cancer	0.000179	0.00056	CcSEcCtD
Sufentanil—Body temperature increased—Triamcinolone—hematologic cancer	0.000178	0.000557	CcSEcCtD
Sufentanil—Anaphylactic shock—Prednisone—hematologic cancer	0.000178	0.000556	CcSEcCtD
Sufentanil—Urethral disorder—Doxorubicin—hematologic cancer	0.000177	0.000555	CcSEcCtD
Sufentanil—Nausea—Irinotecan—hematologic cancer	0.000177	0.000554	CcSEcCtD
Sufentanil—Nausea—Mitoxantrone—hematologic cancer	0.000177	0.000554	CcSEcCtD
Sufentanil—Chills—Epirubicin—hematologic cancer	0.000176	0.000549	CcSEcCtD
Sufentanil—Pruritus—Etoposide—hematologic cancer	0.000175	0.000549	CcSEcCtD
Sufentanil—Arrhythmia—Epirubicin—hematologic cancer	0.000175	0.000547	CcSEcCtD
Sufentanil—Tachycardia—Prednisone—hematologic cancer	0.000173	0.000543	CcSEcCtD
Sufentanil—Nausea—Gemcitabine—hematologic cancer	0.000172	0.00054	CcSEcCtD
Sufentanil—Vomiting—Cisplatin—hematologic cancer	0.000172	0.000539	CcSEcCtD
Sufentanil—Rash—Cisplatin—hematologic cancer	0.000171	0.000534	CcSEcCtD
Sufentanil—Dermatitis—Cisplatin—hematologic cancer	0.00017	0.000534	CcSEcCtD
Sufentanil—Erythema—Epirubicin—hematologic cancer	0.00017	0.000533	CcSEcCtD
Sufentanil—Feeling abnormal—Betamethasone—hematologic cancer	0.000168	0.000526	CcSEcCtD
Sufentanil—Feeling abnormal—Dexamethasone—hematologic cancer	0.000168	0.000526	CcSEcCtD
Sufentanil—Hypersensitivity—Triamcinolone—hematologic cancer	0.000166	0.000519	CcSEcCtD
Sufentanil—Dizziness—Etoposide—hematologic cancer	0.000164	0.000513	CcSEcCtD
Sufentanil—Chills—Doxorubicin—hematologic cancer	0.000162	0.000508	CcSEcCtD
Sufentanil—Dizziness—Prednisolone—hematologic cancer	0.000162	0.000506	CcSEcCtD
Sufentanil—Arrhythmia—Doxorubicin—hematologic cancer	0.000162	0.000506	CcSEcCtD
Sufentanil—Body temperature increased—Betamethasone—hematologic cancer	0.000161	0.000505	CcSEcCtD
Sufentanil—Body temperature increased—Dexamethasone—hematologic cancer	0.000161	0.000505	CcSEcCtD
Sufentanil—Nausea—Cisplatin—hematologic cancer	0.000161	0.000503	CcSEcCtD
Sufentanil—Pruritus—Triamcinolone—hematologic cancer	0.000159	0.000498	CcSEcCtD
Sufentanil—Vomiting—Etoposide—hematologic cancer	0.000158	0.000494	CcSEcCtD
Sufentanil—Erythema—Doxorubicin—hematologic cancer	0.000158	0.000493	CcSEcCtD
Sufentanil—Rash—Etoposide—hematologic cancer	0.000156	0.000489	CcSEcCtD
Sufentanil—Dermatitis—Etoposide—hematologic cancer	0.000156	0.000489	CcSEcCtD
Sufentanil—Headache—Etoposide—hematologic cancer	0.000155	0.000486	CcSEcCtD
Sufentanil—Rash—Prednisolone—hematologic cancer	0.000154	0.000483	CcSEcCtD
Sufentanil—Dermatitis—Prednisolone—hematologic cancer	0.000154	0.000482	CcSEcCtD
Sufentanil—Headache—Prednisolone—hematologic cancer	0.000153	0.00048	CcSEcCtD
Sufentanil—Confusional state—Methotrexate—hematologic cancer	0.00015	0.000469	CcSEcCtD
Sufentanil—Dizziness—Triamcinolone—hematologic cancer	0.000149	0.000466	CcSEcCtD
Sufentanil—Anaphylactic shock—Methotrexate—hematologic cancer	0.000148	0.000465	CcSEcCtD
Sufentanil—Nausea—Etoposide—hematologic cancer	0.000147	0.000461	CcSEcCtD
Sufentanil—Hypertension—Epirubicin—hematologic cancer	0.000147	0.00046	CcSEcCtD
Sufentanil—Feeling abnormal—Prednisone—hematologic cancer	0.000146	0.000458	CcSEcCtD
Sufentanil—Nausea—Prednisolone—hematologic cancer	0.000145	0.000455	CcSEcCtD
Sufentanil—Pruritus—Dexamethasone—hematologic cancer	0.000144	0.000452	CcSEcCtD
Sufentanil—Pruritus—Betamethasone—hematologic cancer	0.000144	0.000452	CcSEcCtD
Sufentanil—Vomiting—Triamcinolone—hematologic cancer	0.000143	0.000448	CcSEcCtD
Sufentanil—Rash—Triamcinolone—hematologic cancer	0.000142	0.000444	CcSEcCtD
Sufentanil—Dermatitis—Triamcinolone—hematologic cancer	0.000142	0.000443	CcSEcCtD
Sufentanil—Headache—Triamcinolone—hematologic cancer	0.000141	0.000441	CcSEcCtD
Sufentanil—Body temperature increased—Prednisone—hematologic cancer	0.00014	0.00044	CcSEcCtD
Sufentanil—Confusional state—Epirubicin—hematologic cancer	0.00014	0.000439	CcSEcCtD
Sufentanil—Anaphylactic shock—Epirubicin—hematologic cancer	0.000139	0.000435	CcSEcCtD
Sufentanil—Hypotension—Methotrexate—hematologic cancer	0.000139	0.000434	CcSEcCtD
Sufentanil—Hypertension—Doxorubicin—hematologic cancer	0.000136	0.000426	CcSEcCtD
Sufentanil—Tachycardia—Epirubicin—hematologic cancer	0.000136	0.000425	CcSEcCtD
Sufentanil—Dizziness—Dexamethasone—hematologic cancer	0.000135	0.000422	CcSEcCtD
Sufentanil—Dizziness—Betamethasone—hematologic cancer	0.000135	0.000422	CcSEcCtD
Sufentanil—Nausea—Triamcinolone—hematologic cancer	0.000134	0.000418	CcSEcCtD
Sufentanil—Somnolence—Methotrexate—hematologic cancer	0.000132	0.000413	CcSEcCtD
Sufentanil—Hypersensitivity—Prednisone—hematologic cancer	0.000131	0.00041	CcSEcCtD
Sufentanil—Hypotension—Epirubicin—hematologic cancer	0.00013	0.000407	CcSEcCtD
Sufentanil—Vomiting—Dexamethasone—hematologic cancer	0.00013	0.000406	CcSEcCtD
Sufentanil—Vomiting—Betamethasone—hematologic cancer	0.00013	0.000406	CcSEcCtD
Sufentanil—Confusional state—Doxorubicin—hematologic cancer	0.00013	0.000406	CcSEcCtD
Sufentanil—Rash—Betamethasone—hematologic cancer	0.000129	0.000403	CcSEcCtD
Sufentanil—Rash—Dexamethasone—hematologic cancer	0.000129	0.000403	CcSEcCtD
Sufentanil—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000129	0.000403	CcSEcCtD
Sufentanil—Dermatitis—Betamethasone—hematologic cancer	0.000129	0.000402	CcSEcCtD
Sufentanil—Dermatitis—Dexamethasone—hematologic cancer	0.000129	0.000402	CcSEcCtD
Sufentanil—Headache—Betamethasone—hematologic cancer	0.000128	0.0004	CcSEcCtD
Sufentanil—Headache—Dexamethasone—hematologic cancer	0.000128	0.0004	CcSEcCtD
Sufentanil—Pruritus—Prednisone—hematologic cancer	0.000126	0.000394	CcSEcCtD
Sufentanil—Tachycardia—Doxorubicin—hematologic cancer	0.000125	0.000393	CcSEcCtD
Sufentanil—Somnolence—Epirubicin—hematologic cancer	0.000124	0.000387	CcSEcCtD
Sufentanil—Feeling abnormal—Methotrexate—hematologic cancer	0.000122	0.000383	CcSEcCtD
Sufentanil—Nausea—Betamethasone—hematologic cancer	0.000121	0.000379	CcSEcCtD
Sufentanil—Nausea—Dexamethasone—hematologic cancer	0.000121	0.000379	CcSEcCtD
Sufentanil—Hypotension—Doxorubicin—hematologic cancer	0.00012	0.000376	CcSEcCtD
Sufentanil—Dizziness—Prednisone—hematologic cancer	0.000118	0.000368	CcSEcCtD
Sufentanil—Body temperature increased—Methotrexate—hematologic cancer	0.000117	0.000368	CcSEcCtD
Sufentanil—Feeling abnormal—Epirubicin—hematologic cancer	0.000115	0.000359	CcSEcCtD
Sufentanil—Somnolence—Doxorubicin—hematologic cancer	0.000114	0.000358	CcSEcCtD
Sufentanil—Vomiting—Prednisone—hematologic cancer	0.000113	0.000354	CcSEcCtD
Sufentanil—Rash—Prednisone—hematologic cancer	0.000112	0.000351	CcSEcCtD
Sufentanil—Dermatitis—Prednisone—hematologic cancer	0.000112	0.00035	CcSEcCtD
Sufentanil—Headache—Prednisone—hematologic cancer	0.000111	0.000349	CcSEcCtD
Sufentanil—Body temperature increased—Epirubicin—hematologic cancer	0.00011	0.000344	CcSEcCtD
Sufentanil—Hypersensitivity—Methotrexate—hematologic cancer	0.000109	0.000343	CcSEcCtD
Sufentanil—Feeling abnormal—Doxorubicin—hematologic cancer	0.000106	0.000332	CcSEcCtD
Sufentanil—Nausea—Prednisone—hematologic cancer	0.000106	0.00033	CcSEcCtD
Sufentanil—Pruritus—Methotrexate—hematologic cancer	0.000105	0.000329	CcSEcCtD
Sufentanil—Hypersensitivity—Epirubicin—hematologic cancer	0.000102	0.000321	CcSEcCtD
Sufentanil—Body temperature increased—Doxorubicin—hematologic cancer	0.000102	0.000318	CcSEcCtD
Sufentanil—Pruritus—Epirubicin—hematologic cancer	9.83e-05	0.000308	CcSEcCtD
Sufentanil—Dizziness—Methotrexate—hematologic cancer	9.82e-05	0.000307	CcSEcCtD
Sufentanil—Fentanyl—ABCB1—hematologic cancer	9.72e-05	0.152	CrCbGaD
Sufentanil—Hypersensitivity—Doxorubicin—hematologic cancer	9.47e-05	0.000297	CcSEcCtD
Sufentanil—Vomiting—Methotrexate—hematologic cancer	9.44e-05	0.000296	CcSEcCtD
Sufentanil—Rash—Methotrexate—hematologic cancer	9.36e-05	0.000293	CcSEcCtD
Sufentanil—Dermatitis—Methotrexate—hematologic cancer	9.35e-05	0.000293	CcSEcCtD
Sufentanil—Headache—Methotrexate—hematologic cancer	9.3e-05	0.000291	CcSEcCtD
Sufentanil—Dizziness—Epirubicin—hematologic cancer	9.19e-05	0.000288	CcSEcCtD
Sufentanil—Pruritus—Doxorubicin—hematologic cancer	9.1e-05	0.000285	CcSEcCtD
Sufentanil—Vomiting—Epirubicin—hematologic cancer	8.84e-05	0.000277	CcSEcCtD
Sufentanil—Nausea—Methotrexate—hematologic cancer	8.82e-05	0.000276	CcSEcCtD
Sufentanil—Rash—Epirubicin—hematologic cancer	8.76e-05	0.000274	CcSEcCtD
Sufentanil—Dermatitis—Epirubicin—hematologic cancer	8.75e-05	0.000274	CcSEcCtD
Sufentanil—Headache—Epirubicin—hematologic cancer	8.71e-05	0.000273	CcSEcCtD
Sufentanil—Dizziness—Doxorubicin—hematologic cancer	8.5e-05	0.000266	CcSEcCtD
Sufentanil—Nausea—Epirubicin—hematologic cancer	8.25e-05	0.000258	CcSEcCtD
Sufentanil—Vomiting—Doxorubicin—hematologic cancer	8.18e-05	0.000256	CcSEcCtD
Sufentanil—Rash—Doxorubicin—hematologic cancer	8.11e-05	0.000254	CcSEcCtD
Sufentanil—Dermatitis—Doxorubicin—hematologic cancer	8.1e-05	0.000254	CcSEcCtD
Sufentanil—Headache—Doxorubicin—hematologic cancer	8.06e-05	0.000252	CcSEcCtD
Sufentanil—Nausea—Doxorubicin—hematologic cancer	7.64e-05	0.000239	CcSEcCtD
Sufentanil—OPRK1—Signaling Pathways—PDGFRA—hematologic cancer	2.12e-05	0.000215	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PRKCG—hematologic cancer	2.12e-05	0.000214	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—JAK1—hematologic cancer	2.12e-05	0.000214	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PC—hematologic cancer	2.11e-05	0.000213	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—JAK2—hematologic cancer	2.09e-05	0.000212	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—MAP2K1—hematologic cancer	2.08e-05	0.000211	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—GRB2—hematologic cancer	2.07e-05	0.00021	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PIK3CD—hematologic cancer	2.07e-05	0.00021	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PDGFA—hematologic cancer	2.07e-05	0.00021	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—FGFR3—hematologic cancer	2.05e-05	0.000207	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KITLG—hematologic cancer	2.04e-05	0.000207	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SLC35B2—hematologic cancer	2.04e-05	0.000206	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GBA—hematologic cancer	2.04e-05	0.000206	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MAPK14—hematologic cancer	2.03e-05	0.000205	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—STAT5A—hematologic cancer	1.99e-05	0.000202	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PIK3CB—hematologic cancer	1.99e-05	0.000201	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ESR1—hematologic cancer	1.99e-05	0.000201	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL2RA—hematologic cancer	1.98e-05	0.0002	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CDKN2B—hematologic cancer	1.98e-05	0.0002	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—FN1—hematologic cancer	1.96e-05	0.000199	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL2—hematologic cancer	1.96e-05	0.000199	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PIK3R1—hematologic cancer	1.96e-05	0.000198	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TERT—hematologic cancer	1.95e-05	0.000198	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—BAD—hematologic cancer	1.94e-05	0.000196	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NFKBIA—hematologic cancer	1.94e-05	0.000196	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NOTCH1—hematologic cancer	1.92e-05	0.000194	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CD86—hematologic cancer	1.91e-05	0.000194	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PDGFB—hematologic cancer	1.91e-05	0.000193	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—JAK2—hematologic cancer	1.9e-05	0.000193	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HES1—hematologic cancer	1.88e-05	0.000191	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CD80—hematologic cancer	1.88e-05	0.000191	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—KIT—hematologic cancer	1.88e-05	0.00019	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CG—hematologic cancer	1.88e-05	0.00019	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—NRAS—hematologic cancer	1.88e-05	0.00019	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NCOR1—hematologic cancer	1.87e-05	0.00019	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TSC2—hematologic cancer	1.86e-05	0.000189	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MTAP—hematologic cancer	1.86e-05	0.000189	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CSF2—hematologic cancer	1.85e-05	0.000188	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FGF1—hematologic cancer	1.85e-05	0.000188	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PTPN11—hematologic cancer	1.84e-05	0.000187	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FOXO1—hematologic cancer	1.83e-05	0.000185	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—IL2—hematologic cancer	1.83e-05	0.000185	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PDGFRB—hematologic cancer	1.82e-05	0.000185	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PIK3CB—hematologic cancer	1.81e-05	0.000183	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—MAPK3—hematologic cancer	1.8e-05	0.000182	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PDGFRA—hematologic cancer	1.79e-05	0.000182	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—FGFR3—hematologic cancer	1.79e-05	0.000182	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—JAK1—hematologic cancer	1.79e-05	0.000181	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PRKCG—hematologic cancer	1.79e-05	0.000181	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CREB1—hematologic cancer	1.79e-05	0.000181	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MAPK14—hematologic cancer	1.78e-05	0.00018	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—BRAF—hematologic cancer	1.77e-05	0.000179	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCL2—hematologic cancer	1.75e-05	0.000177	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL6R—hematologic cancer	1.74e-05	0.000177	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ESR1—hematologic cancer	1.74e-05	0.000176	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CREBBP—hematologic cancer	1.74e-05	0.000176	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—FN1—hematologic cancer	1.72e-05	0.000174	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NFKBIA—hematologic cancer	1.7e-05	0.000172	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—BAD—hematologic cancer	1.7e-05	0.000172	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NOTCH1—hematologic cancer	1.68e-05	0.000171	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL2RA—hematologic cancer	1.67e-05	0.000169	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MAP2K1—hematologic cancer	1.66e-05	0.000168	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—FHL2—hematologic cancer	1.66e-05	0.000168	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL2—hematologic cancer	1.66e-05	0.000168	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TERT—hematologic cancer	1.65e-05	0.000167	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CD—hematologic cancer	1.65e-05	0.000167	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CD80—hematologic cancer	1.65e-05	0.000167	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CG—hematologic cancer	1.65e-05	0.000167	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—KIT—hematologic cancer	1.65e-05	0.000167	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—NRAS—hematologic cancer	1.65e-05	0.000167	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—PIK3CA—hematologic cancer	1.64e-05	0.000166	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—AGRN—hematologic cancer	1.63e-05	0.000165	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PTPN11—hematologic cancer	1.62e-05	0.000164	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—KRAS—hematologic cancer	1.62e-05	0.000164	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PDGFB—hematologic cancer	1.61e-05	0.000163	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—FGF2—hematologic cancer	1.58e-05	0.00016	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—MAPK3—hematologic cancer	1.58e-05	0.00016	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TSC2—hematologic cancer	1.58e-05	0.00016	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CREB1—hematologic cancer	1.57e-05	0.000159	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3R1—hematologic cancer	1.56e-05	0.000158	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—BRAF—hematologic cancer	1.55e-05	0.000157	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—IDH2—hematologic cancer	1.54e-05	0.000156	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HMMR—hematologic cancer	1.54e-05	0.000156	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCL2—hematologic cancer	1.53e-05	0.000155	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL6R—hematologic cancer	1.53e-05	0.000155	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CREBBP—hematologic cancer	1.53e-05	0.000155	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FGFR3—hematologic cancer	1.52e-05	0.000154	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—JAK2—hematologic cancer	1.52e-05	0.000153	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MAPK14—hematologic cancer	1.5e-05	0.000152	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—PIK3CA—hematologic cancer	1.48e-05	0.00015	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MDM2—hematologic cancer	1.48e-05	0.00015	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ESR1—hematologic cancer	1.47e-05	0.000149	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MAP2K1—hematologic cancer	1.46e-05	0.000148	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FN1—hematologic cancer	1.45e-05	0.000147	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.45e-05	0.000147	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CD—hematologic cancer	1.45e-05	0.000147	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CB—hematologic cancer	1.44e-05	0.000146	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MTOR—hematologic cancer	1.44e-05	0.000146	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—BAD—hematologic cancer	1.44e-05	0.000146	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NFKBIA—hematologic cancer	1.44e-05	0.000146	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—PIK3CA—hematologic cancer	1.43e-05	0.000145	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NOTCH1—hematologic cancer	1.42e-05	0.000144	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—KRAS—hematologic cancer	1.42e-05	0.000144	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ACP5—hematologic cancer	1.41e-05	0.000143	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CA9—hematologic cancer	1.41e-05	0.000143	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CD80—hematologic cancer	1.39e-05	0.000141	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.39e-05	0.000141	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CG—hematologic cancer	1.39e-05	0.000141	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KIT—hematologic cancer	1.39e-05	0.000141	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—NRAS—hematologic cancer	1.39e-05	0.000141	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—FGF2—hematologic cancer	1.39e-05	0.00014	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—HRAS—hematologic cancer	1.37e-05	0.000139	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PTPN11—hematologic cancer	1.37e-05	0.000138	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3R1—hematologic cancer	1.37e-05	0.000138	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CDKN1B—hematologic cancer	1.35e-05	0.000137	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—AKT1—hematologic cancer	1.34e-05	0.000135	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—MAPK3—hematologic cancer	1.33e-05	0.000135	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—JAK2—hematologic cancer	1.33e-05	0.000135	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—IDH1—hematologic cancer	1.33e-05	0.000134	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CREB1—hematologic cancer	1.32e-05	0.000134	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CASP3—hematologic cancer	1.32e-05	0.000134	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL2—hematologic cancer	1.32e-05	0.000134	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—IL6—hematologic cancer	1.31e-05	0.000133	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.31e-05	0.000133	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.31e-05	0.000133	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—TXN—hematologic cancer	1.31e-05	0.000133	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—BRAF—hematologic cancer	1.31e-05	0.000132	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PIK3CA—hematologic cancer	1.3e-05	0.000132	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MDM2—hematologic cancer	1.3e-05	0.000131	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCL2—hematologic cancer	1.3e-05	0.000131	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL6R—hematologic cancer	1.29e-05	0.000131	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CREBBP—hematologic cancer	1.29e-05	0.000131	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCND1—hematologic cancer	1.29e-05	0.00013	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—JUN—hematologic cancer	1.29e-05	0.00013	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.28e-05	0.00013	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MTOR—hematologic cancer	1.26e-05	0.000128	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CB—hematologic cancer	1.26e-05	0.000128	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CDKN1A—hematologic cancer	1.25e-05	0.000126	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PTEN—hematologic cancer	1.24e-05	0.000126	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.23e-05	0.000125	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MAP2K1—hematologic cancer	1.23e-05	0.000125	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CD—hematologic cancer	1.22e-05	0.000124	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MAPK8—hematologic cancer	1.22e-05	0.000123	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—AKT1—hematologic cancer	1.21e-05	0.000123	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	1.21e-05	0.000123	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—HRAS—hematologic cancer	1.2e-05	0.000122	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.2e-05	0.000122	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.2e-05	0.000122	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—KRAS—hematologic cancer	1.2e-05	0.000121	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—EP300—hematologic cancer	1.19e-05	0.00012	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CDKN1B—hematologic cancer	1.18e-05	0.00012	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FGF2—hematologic cancer	1.17e-05	0.000119	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—AKT1—hematologic cancer	1.17e-05	0.000119	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.17e-05	0.000118	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CASP3—hematologic cancer	1.16e-05	0.000118	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL2—hematologic cancer	1.16e-05	0.000117	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3R1—hematologic cancer	1.16e-05	0.000117	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SRC—hematologic cancer	1.15e-05	0.000117	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL6—hematologic cancer	1.15e-05	0.000117	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NUP98—hematologic cancer	1.13e-05	0.000115	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCND1—hematologic cancer	1.13e-05	0.000114	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—JUN—hematologic cancer	1.13e-05	0.000114	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—VEGFA—hematologic cancer	1.12e-05	0.000114	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—JAK2—hematologic cancer	1.12e-05	0.000114	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—STAT3—hematologic cancer	1.11e-05	0.000113	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NRAS—hematologic cancer	1.11e-05	0.000112	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PIK3CA—hematologic cancer	1.1e-05	0.000111	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.1e-05	0.000111	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.1e-05	0.000111	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MDM2—hematologic cancer	1.1e-05	0.000111	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CDKN1A—hematologic cancer	1.09e-05	0.000111	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NUP214—hematologic cancer	1.09e-05	0.000111	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PTEN—hematologic cancer	1.09e-05	0.00011	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.07e-05	0.000108	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MTR—hematologic cancer	1.07e-05	0.000108	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MAPK8—hematologic cancer	1.07e-05	0.000108	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MTOR—hematologic cancer	1.07e-05	0.000108	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CB—hematologic cancer	1.07e-05	0.000108	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—AKT1—hematologic cancer	1.06e-05	0.000108	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MAPK3—hematologic cancer	1.06e-05	0.000108	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ENO2—hematologic cancer	1.05e-05	0.000106	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—EP300—hematologic cancer	1.04e-05	0.000105	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MYC—hematologic cancer	1.03e-05	0.000105	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TGFB1—hematologic cancer	1.03e-05	0.000104	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—HRAS—hematologic cancer	1.02e-05	0.000103	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.02e-05	0.000103	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SRC—hematologic cancer	1.01e-05	0.000102	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CDKN1B—hematologic cancer	1e-05	0.000101	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SDC1—hematologic cancer	9.94e-06	0.000101	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—AKT1—hematologic cancer	9.9e-06	0.0001	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—VEGFA—hematologic cancer	9.85e-06	9.97e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CASP3—hematologic cancer	9.81e-06	9.93e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL2—hematologic cancer	9.79e-06	9.92e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—STAT3—hematologic cancer	9.75e-06	9.88e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL6—hematologic cancer	9.74e-06	9.87e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NRAS—hematologic cancer	9.73e-06	9.85e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—KRAS—hematologic cancer	9.55e-06	9.67e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCND1—hematologic cancer	9.55e-06	9.67e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—JUN—hematologic cancer	9.53e-06	9.65e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MAPK3—hematologic cancer	9.32e-06	9.44e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CDKN1A—hematologic cancer	9.24e-06	9.35e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PTEN—hematologic cancer	9.21e-06	9.33e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MYC—hematologic cancer	9.06e-06	9.18e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TGFB1—hematologic cancer	9.04e-06	9.15e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MAPK8—hematologic cancer	9.01e-06	9.13e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—AKT1—hematologic cancer	8.99e-06	9.11e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EP300—hematologic cancer	8.79e-06	8.9e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CA—hematologic cancer	8.77e-06	8.88e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SRC—hematologic cancer	8.55e-06	8.66e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TP53—hematologic cancer	8.49e-06	8.59e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NQO1—hematologic cancer	8.45e-06	8.56e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CD44—hematologic cancer	8.45e-06	8.56e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—KRAS—hematologic cancer	8.37e-06	8.48e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—VEGFA—hematologic cancer	8.32e-06	8.43e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—STAT3—hematologic cancer	8.24e-06	8.35e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NRAS—hematologic cancer	8.22e-06	8.33e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HRAS—hematologic cancer	8.12e-06	8.22e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYCS—hematologic cancer	8e-06	8.1e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	7.95e-06	8.05e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MAPK3—hematologic cancer	7.87e-06	7.97e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL6—hematologic cancer	7.77e-06	7.87e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CA—hematologic cancer	7.69e-06	7.79e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MYC—hematologic cancer	7.66e-06	7.76e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TGFB1—hematologic cancer	7.64e-06	7.74e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TP53—hematologic cancer	7.44e-06	7.54e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AKT1—hematologic cancer	7.17e-06	7.26e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HRAS—hematologic cancer	7.12e-06	7.21e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KRAS—hematologic cancer	7.08e-06	7.17e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTP1—hematologic cancer	7.05e-06	7.14e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL6—hematologic cancer	6.81e-06	6.9e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ABCB1—hematologic cancer	6.67e-06	6.76e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CA—hematologic cancer	6.5e-06	6.58e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTM1—hematologic cancer	6.48e-06	6.56e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NCOR1—hematologic cancer	6.48e-06	6.56e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TP53—hematologic cancer	6.29e-06	6.37e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AKT1—hematologic cancer	6.28e-06	6.36e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HRAS—hematologic cancer	6.01e-06	6.09e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL6—hematologic cancer	5.76e-06	5.83e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MTHFR—hematologic cancer	5.73e-06	5.8e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AKT1—hematologic cancer	5.31e-06	5.38e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CG—hematologic cancer	4.81e-06	4.87e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CREBBP—hematologic cancer	4.46e-06	4.52e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CD—hematologic cancer	4.23e-06	4.28e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALB—hematologic cancer	4.17e-06	4.23e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3R1—hematologic cancer	3.99e-06	4.04e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CB—hematologic cancer	3.69e-06	3.73e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PTEN—hematologic cancer	3.19e-06	3.23e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—EP300—hematologic cancer	3.04e-06	3.08e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CA—hematologic cancer	2.25e-06	2.28e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—AKT1—hematologic cancer	1.84e-06	1.86e-05	CbGpPWpGaD
